South Korea's Green Cross to supply Americas with flu vaccine

South Korea's Green Cross announced a $32 million deal on Wednesday to supply its flu vaccines to the Pan American Health Organization, the WHO's regional office in the Americas. With the new deal, Green Cross' vaccine exports will surpass the $150 million mark, the company said as quoted by the Korea Herald. And the company has further designs on the Americas, planning to participate in a PAHO-led procurement bid for use in North American countries slated for the second half of this year. Read more

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.